Rhonda Hoffman joins Bactolife™ as Board Member
We are delighted to introduce Rhonda Hoffman as our newest addition to the Board of Directors Rhonda is a distinguished and seasoned C-suite leader within the nutrition industry, with a long track record from prominent industry organizations in the food ingredient space, including Pharmavite, Abbott Laboratories, Vrios, and P&G. With a breadth of experience that […]
Novozymes and Bactolife join forces to significantly reduce post weaning diarrhea and antibiotic use among weaner pigs
The two companies have signed a joint development and commercialization agreement to launch feed additive Ablacto+. The game changing biosolution uses binding proteins to stabilize the gut of piglets, thereby reducing the need for antibiotic consumption. Copenhagen, Denmark – 4 September 2023. Novozymes and the Danish industrial biotech company, Bactolife, have signed a joint development […]
Bactolife Raises EUR 30 million in Series A Financing
COPENHAGEN, Denmark, 08 August, 2023 – Bactolife A/S (“Bactolife”), a bioindustrial company developing proprietary Binding ProteinsTM, which strengthen the gut microbiome of humans and animals with the aim of reducing the burden of gastrointestinal infections and anti-microbial resistance, today announced that it has successfully raised EUR >30 million since its April 2021 seed round. The […]
Bactolife appoints Jens Møller Nielsen as COO
Bactolife A/S is pleased to welcome Jens Møller Nielsen who takes up the position as COO as of 1 March 2023. Jens joins Bactolife to further strengthen the management and operations teams. He brings solid international management experience within upscaling and production most recently from Coloplast and Topsoe and prior to those 19 years with […]
Bactolife™ receives USD 5 million in new funding to address gastrointestinal infections worldwide
The Bill & Melinda Gates Foundation is investing to accelerate Bactolife™’s mission of developing effective and affordable food and feed ingredients to combat some of the largest gut health issues worldwide. COPENHAGEN, Denmark, 30 August 2022 – Bactolife™ today announced that the Bill & Melinda Gates Foundation has committed, in alignment with the foundation’s charitable […]
Thomas Schäfer joins Bactolife™ as Scientific Advisor
We are proud to announce that Thomas Schäfer is joining Bactolife™ as Scientific Advisor. Thomas holds a PhD in Microbiology, Physiology and Biochemistry, and has a rich background within biotech innovation, microbial discovery and development, and leadership from his roles in Novozymes and Chr. Hansen. Latest he served as CSO at Chr. Hansen before stepping […]
Internship, thesis or assertation proposals
Interested in doing an internship at Bactolife, or do you have a thesis or assertation proposal that you would like to share with us?
Unsolicited application
We are always looking for exceptional talent to join our team. Write us here if you did not find a suitable position
Eat your intestines strong
Simple supplement to reduce the risk of gastrointestinal infections from coli bacteria. In addition to saving people from unpleasant experiences, supplements can be used in the fight against diarrhea, which is globally one of the most common causes of infant death. The Innovation Fund invests DKK 11 million in the ColiShield™
Bactolife™ Raises EURm 7 in Seed Financing
Novo Holdings is investing EUR 5 million of the total funding of EUR 7 million in Bactolife, which is one of the largest bioindustrials seed round investments in Europe
